ストックスクリーナーアプリを入手
5.16
0.58%
0.03
アフターアワーズ：
5.16
前日終値:
$5.13
開ける：
$5.13
24時間の取引高:
147.96K
Relative Volume:
0.48
時価総額：
$193.38M
収益：
$147.12M
当期純損益:
$-33.88M
株価収益率:
-4.8574
EPS:
-1.0623
ネットキャッシュフロー:
$2.63M
1週間 パフォーマンス:
+0.78%
1か月 パフォーマンス:
+34.38%
6か月 パフォーマンス:
-23.78%
1年 パフォーマンス:
-26.50%
1日の値動き範囲:
$5.10
$5.37
1週間の範囲:
$4.91
$5.37
52週間の値動き範囲:
$3.625
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Compare LFCR vs TAK, ZTS, TEVA, HLN, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
5.16 | 192.26M | 147.12M | -33.88M | 2.63M | -1.0623 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-17 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2025-09-04 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | 開始されました | William Blair | Outperform |
| 2024-09-05 | 開始されました | Craig Hallum | Buy |
| 2024-08-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | ダウングレード | Stephens | Overweight → Equal-Weight |
すべてを表示
Lifecore Biomedical Inc (LFCR) 最新ニュース
MSN Money - MSN
Before the bell May 6, Lifecore releases Q1 results, holds 8 a.m. webcast - Stock Titan
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical (LFCR) price target decreased by 25.71% to 6.63 - MSN
[DEF 14A] LIFECORE BIOMEDICAL, INC. DE Definitive Proxy Statement - Stock Titan
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Lifecore hire gets 5,000 stock units that vest in 3 years - Stock Titan
Lifecore (NASDAQ: LFCR) executive RSU vesting leads to 24,645 shares withheld for tax - Stock Titan
The Technical Signals Behind (LFCR) That Institutions Follow - Stock Traders Daily
Will Lifecore Biomedical (LFCR) Stock Rise in 2026 | Price at $4.88, Up 2.74%Expert Verified Trades - Xã Châu Thành
Current Report Filing (8-k) - ADVFN
Amended Statement of Ownership (sc 13g/a) - ADVFN
Form 8-KCurrent report - ADVFN
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Form POS AMPost-Effective amendments for registration statement - ADVFN
Form DEF 14AOther definitive proxy statements - ADVFN
If You Invested $1,000 in Lifecore Biomedical Inc (LFCR) - Stock Titan
Lifecore Biomedical Receives 'Hold' Rating from Analysts - National Today
LFCR.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Death Cross: Is Lifecore Biomedical Inc on track to beat earningsEarnings Beat & Daily Profit Focused Screening - baoquankhu1.vn
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit - Sahm
Retail Surge: Is Lifecore Biomedical Inc trading at a discountWeekly Stock Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Inflation Data: Is Lifecore Biomedical Inc a strong candidate for buy and holdBear Alert & AI Enhanced Trading Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect - ACCESS Newswire
2026-04-07 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Merger Talk: Is Lifecore Biomedical Inc forming bullish engulfing patterns2026 Pullbacks & Real-Time Buy Zone Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - GlobeNewswire Inc.
LFCR Should I Buy - Intellectia AI
LFCR PE Ratio & Valuation, Is LFCR Overvalued - Intellectia AI
LFCR Technical Analysis & Stock Price Forecast - Intellectia AI
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - Yahoo Finance
LFCR News & Events - Intellectia AI
Landec Corp. (US5147661046.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Transition period Earnings Call Transcript - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Momentum Shift: Can Lifecore Biomedical Inc continue delivering strong returns2026 Trade Ideas & Intraday High Probability Alerts - baoquankhu1.vn
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Buybacks Report: Is Lifecore Biomedical Inc a top pick in the sectorNew Guidance & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Claim your share of the $3.75M Lifecore Biomedical securities class action settlement - Claim Depot
Lifecore Biomedical Earnings Call Signals Profitable Shift - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Inc (LFCR) 財務データ
収益
当期純利益
現金流量
EPS
0.67%
2.13%
大文字化:
|
ボリューム (24 時間):